SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022672
Filing Date
2022-02-14
Accepted
2022-02-14 16:04:16
Documents
2
Group Members
CORRIENTE MASTER FUND II, LPMARK L. HART III

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm226234d1_sc13ga.htm SC 13G/A 85664
2 EXHIBIT 99.A tm226234d1_ex99-a.htm EX-99.A 4315
  Complete submission text file 0001104659-22-022672.txt   91815
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Subject) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80378 | Film No.: 22631288
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107
Business Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107 8178700400
Corriente Advisors, LLC (Filed by) CIK: 0001406718 (see all company filings)

IRS No.: 752939516 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A